Kenneth C. Cundy
Net Worth
Last updated:
What is Kenneth C. Cundy net worth?
The estimated net worth of Dr. Kenneth C. Cundy is at least $4,681,712 as of 11 Aug 2021. He has earned $46,212 from insider trading and has received compensation worth at least $4,635,500 in CohBar, Inc..
What is the salary of Kenneth C. Cundy?
Dr. Kenneth C. Cundy salary is $463,550 per year as Chief Scientific Officer in CohBar, Inc..
How old is Kenneth C. Cundy?
Dr. Kenneth C. Cundy is 66 years old, born in 1959.
What stocks does Kenneth C. Cundy currently own?
As insider, Dr. Kenneth C. Cundy owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
CohBar, Inc. (CWBR) | Chief Scientific Officer | 10,000 | $0 | $0 |
What does CohBar, Inc. do?
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
Kenneth C. Cundy insider trading
CohBar, Inc.
Dr. Kenneth C. Cundy has made 15 insider trades between 2015-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 10,000 units of CWBR stock on 22 May 2015. As of 11 Aug 2021 he still owns at least 10,000 units of CWBR stock.
CohBar key executives
CohBar, Inc. executives and other stock owners filed with the SEC:
- Dr. Kenneth C. Cundy (66) Chief Scientific Officer
- Mr. Jeffrey F. Biunno CPA, M.B.A., CPA, MBA (59) Chief Financial Officer, Treasurer & Sec.